lunes, 19 de noviembre de 2018

For CF Children Ages 2-5, Orkambi Closer to Being Approved in Europe

For CF Children Ages 2-5, Orkambi Closer to Being Approved in Europe

Cystic Fibrosis News Today

Orkambi Closer to Being Approved in Europe to Treat Children Ages 2-5 With Cystic Fibrosis

No hay comentarios:

Publicar un comentario